AAM Urges FDA To Reassess Nitrosamines

Generics Industry Body Proposes Science-Driven, Risk-Based Approach

 
• By Akriti Seth
  
International Carcinogen Hazard Symbol,Yellow warning Dangerous icon isolated on white background, Attracting attention, Compulsory, Control, practice, Security first sign, Vector, EPS10
The generics industry proposes proactive actions to FDA to mitigate nitrosamine-related challenges • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products